Clinical trial · Observational
A Multicenter Study of Clinical Epidemiology of Breast Cancer in Shaanxi Province of China
A Multicenter Study of Clinical Epidemiology of Breast Cancer in Shaanxi Province of China (Based on Hospital)
NCT02493569CI-TRIAL-00023424unknownClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The purpose of the study is to study the epidemic features and diagnosis of female breast cancer, especially the diagnosis and treatment of breast cancer.The disease-free survival (DFS) and the total survival time(OS) of the breast cancer patients will also be studied.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Breast Cancer | Malignant Breast Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| The radical mastectomy of breast cancer | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- Epidemiology breast cancer patients
- description
- Observe the features of clinical diagnosis and treatment for female breast cancer patients
- interventionNames
- Procedure: The radical mastectomy of breast cancer
Primary outcomes (1)
- measure
- Overall five-year survival for the female breast cancer patients
- timeFrame
- 5 years
Eligibility
Eligibility (as posted)
- Sex
- Female
Show eligibility criteria text
Inclusion Criteria: * Female patients; * The hospitalized patients who are confirmed of the primary breast cancer histologically; * The date of the inpatients are within the month we chosen; * Patients who are within the month we chosen have been received or under receiving the relevant treatment including surgical treatment, chemotherapy and radiotherapy. Exclusion Criteria: * Male breast cancer patients; * Patients with breast cancer who are not under the chosen time; * Non hospitalized patients.
References
Publications (0)
Data not yet available
No reference posted for this study.